###begin article-title 0
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 162 165 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-1 expression induces cyclin D1 expression and pRb phosphorylation in infected podocytes: cell-cycle mechanisms contributing to the proliferative phenotype in HIV-associated nephropathy
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 372 373 372 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 444 445 444 445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 109 112 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 168 173 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 322 327 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The aberrant cell-cycle progression of HIV-1-infected kidney cells plays a major role in the pathogenesis of HIV-associated nephropathy, however the mechanisms whereby HIV-1 induces infected glomerular podocytes or infected tubular epithelium to exit quiescence are largely unknown. Here, we ask whether the expression of HIV-1 genes in infected podocytes induces cyclin D1 and phospho-pRb (Ser780) expression, hallmarks of cyclin D1-mediated G1 --> S phase progression.
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 20 21 20 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 426 427 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 474 475 474 475 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 559 560 557 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 578 579 576 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 733 734 731 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 883 884 881 882 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 969 970 967 968 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1003 1006 1001 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 1032 1033 1030 1031 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 94 97 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 135 140 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 177 182 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 183 198 <span type="species:ncbi:10090">transgenic mice</span>
###xml 200 204 <span type="species:ncbi:10090">Tg26</span>
###xml 259 264 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 339 343 <span type="species:ncbi:10090">Tg26</span>
###xml 501 506 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 753 758 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 789 794 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 928 933 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 980 985 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We assessed cyclin D1 and phospho-pRb (Ser780) expression in two well-characterized models of HIV-associated nephropathy pathogenesis: HIV-1 infection of cultured podocytes and HIV-1 transgenic mice (Tg26). Compared to controls, cultured podocytes expressing HIV-1 genes, and podocytes and tubular epithelium from hyperplastic nephrons in Tg26 kidneys, had increased levels of phospho-pRb (Ser780), a target of active cyclin D1/cyclin-dependent kinase-4/6 known to promote G1 --> S phase progression. HIV-1-infected podocytes showed markedly elevated cyclin D1 mRNA and cyclin D1 protein, the latter of which did not down-regulate during cell-cell contact or differentiation, suggesting post-transcriptional stabilization of cyclin D1 protein levels by HIV-1. The selective suppression of HIV-1 transcription by the cyclin-dependent kinase inhibitor, flavopiridol, abrogated cyclin D1 expression, underlying the requirement for HIV-1 encoded products to induce cyclin D1. Indeed, HIV-1 virus deleted of nef failed to induce cyclin D1 mRNA to the level of other single gene mutant viruses.
###end p 4
###begin title 5
Conclusions
###end title 5
###begin p 6
###xml 33 34 33 34 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 110 115 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 expression induces cyclin D1 and phospho-pRb (Ser780) expression in infected podocytes, suggesting that HIV-1 activates cyclin D1-dependent cell-cycle mechanisms to promote proliferation of infected renal epithelium.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 557 558 557 558 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 599 607 599 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 612 619 612 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 901 902 901 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 903 904 903 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 966 967 966 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 968 970 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1191 1193 1191 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1194 1196 1194 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 119 124 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 384 387 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 474 479 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 662 667 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 779 784 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 803 808 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1028 1033 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
###xml 1066 1070 <span type="species:ncbi:10116">rats</span>
###xml 1178 1183 <span type="species:ncbi:9606">human</span>
###xml 1245 1250 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Proliferation and dedifferentiation of HIV-1 infected renal epithelium is singularly unique compared to the effects of HIV-1 infection in other non-lymphoid tissues. Indeed, unlike the atrophy and cell-death of infected central nervous system [1], cardiac [2], or gastro-intestinal [3] parenchyma, aberrant cell-cycle progression of infected renal epithelium is a defining feature of HIV-associated nephropathy (HIVAN) [4,5]. Yet, the mechanisms are largely unknown whereby HIV-1 subverts the cell-cycle controls that normally maintain renal epithelial in G0. Nonetheless, several observations from in vitro and in vivo models of HIVAN pathogenesis suggest that HIV-1 expression itself may be a key pathogenic factor. Infection of cultured podocytes with replication incompetent HIV-1 demonstrated that HIV-1 gene expression leads to the proliferation and dedifferentiation of the infected podocytes [6-8], recapitulating the phenotypes observed in HIVAN specimens [9,10]. Similarly, renal expression of replication incompetent HIV-1 proviral transgenes in mice and rats produces a proliferative renal lesion that is indistiguisable both histopathologically and clinically from human HIVAN [11-14]. These observations raise the possibility that HIV-1 gene products may interact with mitogenic pathways in infected renal epithelium to cause aberrant cell-cycle engagement.
###end p 8
###begin p 9
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 654 655 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 769 770 769 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">c</italic>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 873 874 873 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1079 1080 1077 1078 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 1115 1116 1113 1114 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1137 1144 1135 1142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 1267 1269 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1356 1358 1354 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1470 1472 1468 1470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1526 1527 1524 1525 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1626 1628 1624 1626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1683 1685 1681 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 264 269 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 416 421 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 796 801 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 869 872 <span type="species:ncbi:12814?0.7497633322814768|species:ncbi:11886?0.2234143262858946|species:ncbi:12331?0.0041022404544020195">RSV</span>
In comparison to the two general alternative mechanisms utilized by known transforming viruses to promote cell-cycle progression, namely, by activating or bypassing endogenous D-type cyclins (herein, referred to as "cyclin D"), it has not been established whether HIV-1 gene products trigger either cyclin D-dependent or cyclin D-independent proliferation in non-lymphoid tissues [15]. In infected renal epithelium, HIV-1 could disrupt the inhibitory binding of pRb to E2F independent of endogenous cyclin D, analogous to transforming viral mechanisms that bypass and down-regulate endogenous cyclin D, such as SV-40 T antigen binding to pRb [16], HHV-8 v-cyclin binding to and activating cyclin-dependent kinase-6 (CDK) [17], and activation of cyclin E by EBV-induced c-myc [18]. Alternatively, HIV-1 could activate cyclin D-dependent proliferation, as exemplified by RSV v-src-mediated signaling [19]. In most tissues, the selective activation of these cell-cycle pathways is readily discernable. Indeed, if cells depend on cyclin D-mediated G1 --> S transition, passage from G0 through the restriction point in G1 is dependent on the de novo expression of cyclin D transcript, accumulation of nuclear cyclin D protein, and cyclin D/CDK-4/6 phosphorylation of pRb [20]. Then, although nuclear-localized cyclin D decreases in S phase in individual cells [21], total cyclin D in asynchronously proliferating cell populations remain elevated compared to quiescent cells [20]. In renal epithelial and mesenchymal cells, cyclin D1 is the dominant D-type cyclin activated during cell-cycle progression, both during nephrogenesis [22] and in non-viral-mediated kidney cell proliferation [23].
###end p 9
###begin p 10
###xml 93 94 93 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 162 163 162 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 287 288 287 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 537 538 537 538 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 598 599 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 51 56 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 415 420 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 421 436 <span type="species:ncbi:10090">transgenic mice</span>
###xml 449 454 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Here, we ask whether infected podocytes expressing HIV-1 genes show the hallmarks of cyclin D1-dependent proliferation, specifically the up-regulation of cyclin D1 transcript and protein expression and the subsequent phosphorylation of pRb on serine 780, a target site of active cyclin D1/CDK-4/6 that is not shared with cyclin E/CDK-2 complexes [24]. Utilizing two well-characterized models of HIVAN pathogenesis, HIV-1 transgenic mice [11-13] and HIV-1 infection of cultured podocytes [6-8] we find not only these hallmarks of cyclin D1-dependent proliferation, but also dysregulation of cyclin D1 expression that normally occurs with cell-cell contact and differentiation [25].
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
Phospho-pRb (Ser780) expression in vivo
###end title 12
###begin p 13
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 188 189 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 352 354 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 355 357 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 414 421 408 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gag-pol</italic>
###xml 692 693 686 687 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 921 922 915 916 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1023 1024 1017 1018 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1044 1046 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1056 1057 1048 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1353 1355 1345 1347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1385 1386 1377 1378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 260 265 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 306 311 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 323 328 <span type="species:ncbi:10090">mouse</span>
###xml 336 340 <span type="species:ncbi:10090">Tg26</span>
###xml 397 402 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 453 457 <span type="species:ncbi:10090">Tg26</span>
###xml 646 651 <span type="species:ncbi:9606">human</span>
Cyclin D1 is characterized as the major D-type cyclin controlling G1-phase progression in kidney cells, both during normal and abnormal proliferation [22,23]. To determine whether cyclin D1 may be active in promoting G1 --> S progression in kidneys expressing HIV-1 genes, we utilized a well-characterized HIV-1 transgenic mouse model (Tg26) of HIVAN [11-13]. Secondary to renal expression of the HIV-1 NL4-3 Deltagag-pol proviral transgene, adolescent Tg26 transgenics develop a progressive, proliferative renal disease marked by podocyte and tubular epithelial hyperplasia that is indistinguishable both clinically and histopathologically from human HIVAN. In order to determine if cyclin D1 plays a role in this hyperplasia, kidneys from three proteinuric 40-day old transgenic siblings and three non-transgenic littermates were stained by immunohistochemistry with antibody to phospho-pRb (Ser780), a site of cyclin D1/CDK-4/6 phosphorylation not targeted by cyclin E/CDK-2 complexes that disrupts pRb/E2F binding for G1 --> S progression [24]. Figure 1 depicts the intense, heterogeneous nuclear staining of glomerular podocytes and tubular epithelium from hyperplastic nephrons in the diseased transgenics versus the absent staining of nephrons in the non-transgenics consistent with the very low mitotic index in normal kidneys of adult animals [26]. This suggests that cyclin D1 is promoting cell-cycle progression during the proliferation of epithelium in diseased kidneys.
###end p 13
###begin p 14
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 0 76 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>In situ</italic> immunodetection of phosphorylated serine 780 on pRb in Tg26 kidneys.</bold>
###xml 161 162 161 162 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 329 331 329 331 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B)</bold>
###xml 350 351 350 351 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 369 370 369 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 63 67 <span type="species:ncbi:10090">Tg26</span>
In situ immunodetection of phosphorylated serine 780 on pRb in Tg26 kidneys. Phospho-pRb (Ser780) is not detected in the nuclei of epithelium of normal kidneys (A), but is readily detected in podocytes (short arrows) and tubular epithelial cells (long arrows) in hyperplastic nephrons of diseased transgenic kidneys at cortical (B), juxta-medullary (C), and medullary (D) depths. The prominent staining in many, but not all nuclei, is characteristic of asynchronously proliferating cells. (magnification = 40x)
###end p 14
###begin title 15
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Cyclin D1 and phospho-pRb (Ser780) expression in vitro
###end title 15
###begin p 16
###xml 132 140 132 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo,</italic>
###xml 233 234 233 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 304 305 304 305 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 761 762 761 762 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 975 976 975 976 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1129 1130 1129 1130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1241 1242 1241 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1243 1245 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1363 1364 1363 1364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1423 1424 1423 1424 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1527 1528 1527 1528 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1751 1752 1751 1752 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1821 1823 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1954 1956 1954 1956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 2001 2002 2001 2002 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2109 2110 2109 2110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 2193 2194 2193 2194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2253 2254 2253 2254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2265 2266 2265 2266 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2331 2332 2329 2330 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 849 854 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 906 911 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1060 1065 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1306 1311 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1484 1489 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1555 1560 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1855 1860 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2138 2143 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 expression in cultured podocytes recapitulates the phenotypic abnormalities induced by HIV-1 expression in infected podocytes in vivo, specifically proliferation, loss of contact-mediated growth control, and dedifferentiation [6-8]. To determine if these phenotypes were marked by enhanced cyclin D1 and phospho-pRb (Ser780) expression, we utilized the podocyte cell-culture protocol developed by Rieser et al. [27,28] to study both sub-confluent podocyte growth and podocyte growth during the formation of mature cell-cell contacts at confluence. In this protocol, normal podocytes are growth-arrested 4-5 days after initial confluence and are fully differentiated with mature cell-cell contacts approximately 10 days later. Figure 2A shows that cyclin D1 message levels are nearly equivalent between mock ("wild-type")-, control virus-, and HIV-1-infected subconfluent podocytes, although only the HIV-1-infected subconfluent podocytes had elevated levels of cyclin D1 protein. In contrast, cell-cell contact in wild-type and control-infected, but not HIV-1-infected podocytes, caused a severe down-regulation of cyclin D1 transcript and protein concomitant with the up-regulation of synaptopodin, a podocyte differentiation marker [7,28], by the end of the 14-day differentiation period. Although HIV-1 infected podocytes showed some decrease in cyclin D1 message by the end of the differentiation period, cyclin D1 protein levels remained elevated, suggesting activation by HIV-1 of mechanisms that stabilize cyclin D1 protein levels. Moreover, HIV-1-infected podocytes, but not control-infected podocytes, had readily detectable phospho-pRb (Ser780) at the end of the differentiation period, suggesting that the stably up-regulated cyclin D1 protein remained active in promoting cell-cycle progression (Figure 2B). The ongoing proliferation of HIV-1-infected podocytes following cell-cell contact led to the formation of multiple foci (Figure 2C) with intense, heterogenous nuclear cyclin D1 immunofluorescence consistent with ongoing asynchronous proliferation in this population of cells (Figure 3). These data indicate that HIV-1 expression in infected podocytes induces cyclin D1 and phospho-pRb (Ser780) expression, hallmarks of cyclin D1-mediated G1 --> S progression. The data, however, do not prove that cyclin D1 expression alone is sufficient to cause cell-cycle progression.
###end p 16
###begin p 17
###xml 22 23 22 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of cyclin D<sub>1</sub> and phospho-pRb (Ser780) in HIV-1-infected podocytes.</bold>
###xml 79 80 79 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 129 130 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 355 356 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 393 394 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 716 717 704 705 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 978 979 960 961 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 52 57 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 178 183 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 406 411 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 482 487 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 844 849 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1018 1023 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1127 1132 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Expression of cyclin D1 and phospho-pRb (Ser780) in HIV-1-infected podocytes. (A) Northern and western blot detection of cyclin D1 expression in wild-type, control-infected, and HIV-1-infected podocytes during subconfluent (SC) growth at 33degreesC and during 14 days of differentiation of confluent podocytes at 37degreesC shows that neither the cyclin D1 transcript nor the elevated cyclin D1 protein in HIV-1-infected podocytes (full-length, singly-spliced, and multiply spliced HIV-1 transcripts) are significantly down-regulated by podocyte cell-cell contact or by podocyte differentiation (synaptopodin transcript) when compared to wild-type or control-infected (one transcript from LTR sequences) podocytes. (B) Immunodetection of phospho-pRb (Ser780) on several phosphorylated forms (arrows) of pRb in the asynchronously proliferating, HIV-1-infected podocytes that is absent in the quiescent, control-infected podocytes after 14 days of differentiation at 37degreesC. (C) Abundant foci formation in confluent HIV-1-infected podocytes but not in confluent control-infected podocytes due to the ongoing proliferation of HIV-1-infected podocytes after cell-cell contact. Blots are representative of two independent experiments.
###end p 17
###begin p 18
###xml 45 46 45 46 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Heterogenous nuclear localization of cyclin D<sub>1</sub> in HIV-1-infected podocytes.</bold>
###xml 123 124 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 251 252 245 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 322 323 316 317 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 441 442 435 436 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 447 448 441 442 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 390 395 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Heterogenous nuclear localization of cyclin D1 in HIV-1-infected podocytes. Immunofluorescent detection of nuclear cyclin D1 in quiescent, wild-type podocytes after 14 days of differentiation at 37degreesC shows light speckled staining in all nuclei (A). This differs markedly from the intense nuclear staining of cyclin D1 in some, but not all nuclei, of the asynchronously proliferating, HIV-1-infected podocytes (GFP positive podocytes) (B and C). (magnification = 100x)
###end p 18
###begin title 19
###xml 57 58 57 58 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Requirement of HIV-1 expression for induction of cyclin D1
###end title 19
###begin p 20
###xml 130 131 130 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 471 472 471 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 699 700 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 880 881 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1003 1004 1003 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1059 1060 1059 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1138 1139 1138 1139 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1172 1173 1172 1173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1353 1356 1353 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tat</italic>
###xml 1403 1406 1403 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 1465 1466 1465 1466 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1528 1529 1528 1529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1594 1595 1594 1595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1653 1656 1653 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 34 39 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 331 336 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 567 572 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 640 645 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 684 689 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 904 909 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 983 988 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1052 1057 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1081 1086 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1219 1224 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1339 1344 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1616 1621 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1647 1652 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We sought to further confirm that HIV-1 expression, and not some idiosyncratic effect of infection, was directly inducing cyclin D1 expression in infected podocytes. First, we utilized the small molecule cyclin-dependent kinase inhibitor, flavopiridol, which at low concentrations (e.g., less than 100 nM) can selectively suppress HIV-1 transcript elongation without altering cellular transcripts in cell types of various lineages, including podocytes [7,29,30]. Cyclin D1 transcript levels were followed before, during, and after treatment of confluent wild-type or HIV-1 infected podocytes with 50 nM flavopiridol, a dose that suppresses HIV-1 transcription by 70% [7]. Analysis of HIV-1, cyclin D1, and glyceraldehyde-3-phosphate dehydrogenase (G3PDH) transcript levels in podocytes treated with flavopiridol for 2 days, followed by drug washout for 1 day, showed that cyclin D1 expression paralleled HIV-1 expression in infected podocytes before, during and after suppression of HIV-1 genes (Figure 4). Secondly, we utilized single gene mutants of HIV-1 [8] to determine which HIV-1 gene(s) may be involved with up-regulating cyclin D1 expression. Analysis of cyclin D1 transcript levels in podocytes infected with HIV-1 singly mutated with premature stop codons in the genes encoding the various structural and regulatory proteins of HIV-1 (except tat, which is present in every virus) showed that nef-deficient virus did not significantly up-regulate cyclin D1 expression when compared to the other mutant viruses (Figure 5). Taken together, these data indicate that induction of cyclin D1 expression requires HIV-1 gene expression and that HIV-1 nef is important for this induction.
###end p 20
###begin p 21
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Parallel expression of HIV-1 and cyclin D<sub>1</sub>.</bold>
###xml 87 88 87 88 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 366 367 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 240 245 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 324 329 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 389 394 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Parallel expression of HIV-1 and cyclin D1. Northern blot de tection of HIV-1, cyclin D1, and G3PDH transcripts before (day 14), during (two days with drug, day 16), and after (one day after drug washout, day 17) treatment of wild-type and HIV-1-infected podocytes with 50 nM flavopiridol, a small molecule CDK inhibitor of HIV-1 transcription, showing that cyclin D1 expression parallels HIV-1 expression. Blot is representative of two independent experiments.
###end p 21
###begin p 22
###xml 43 44 43 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mapping of HIV-1 genes that induce cyclin D<sub>1</sub> expression.</bold>
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tat</italic>
###xml 329 332 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 391 392 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 154 159 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 216 221 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 343 348 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Mapping of HIV-1 genes that induce cyclin D1 expression. Northern blot detection of cyclin D1 and G3PDH transcripts from wild-type, control-infected, and HIV-1-infected podocytes infected with single gene mutants of HIV-1 (tat present in every virus). Similar to wild-type and control-infected podocytes, podocytes infected with nef-deficient HIV-1 do not significantly up-regulated cyclin D1 expression compared to podocytes infected with other single gene mutant viruses.
###end p 22
###begin title 23
Discussion
###end title 23
###begin p 24
###xml 198 199 198 199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 261 262 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 385 386 385 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 446 454 446 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 459 467 459 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo.</italic>
###xml 577 578 577 578 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 813 814 813 814 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 888 889 888 889 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1163 1164 1163 1164 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1177 1179 1177 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1218 1219 1218 1219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1311 1312 1311 1312 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1418 1419 1418 1419 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1468 1469 1468 1469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 153 158 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 523 528 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 729 734 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1039 1044 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1238 1243 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1337 1342 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The mechanisms whereby HIV-1 subverts cell-cycle controls in infected renal epithelium have been unclear. Here, we demonstrate that podocytes expressing HIV-1 genes display the hallmarks of cyclin D1-dependent cell-cycle progression, specifically, that cyclin D1 transcript and protein expression are markedly up-regulated, and that levels of phospho-pRb (Ser780), a target of cyclin D1/CDK-4/6 but not cyclin E/CDK-2 complexes [24], are induced in vitro and in vivo. In addition, preliminary micro-array gene profiling of HIV-1-infected tubular epithelium showed that cyclin D1 expression is up-regulated several fold when compared to uninfected tubular epithelium (Michael Ross, personal communication). This suggests that the HIV-1-induced proliferation of infected renal epithelium may be caused by a cyclin D1-dependent mechanism, unlike other viruses that bypass a requirement for G1-phase cyclins to trigger aberrant cell-cycle progression. Moreover, normal cellular controls on cell-cycle progression appears to be dysregulated by HIV-1 expression because cell-cell contact and differentiation, events that normally lead to the down-regulation of cyclin D1 expression [25], did not significantly alter cyclin D1 protein levels in HIV-1 infected podocytes. This suggests a novel stabilization of cyclin D1 protein in podocytes by HIV-1. We are exploring whether this occurs from enhanced translation of cyclin D1 message and/or decreased degradation of cyclin D1 protein and whether other D-type cyclins may be involved in phosphorylating pRb in HIVAN.
###end p 24
###begin p 25
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 549 557 549 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 853 854 853 854 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 864 872 864 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 988 991 988 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef</italic>
###xml 1026 1029 1026 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">tat</italic>
###xml 1193 1194 1193 1194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1277 1278 1277 1278 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1350 1351 1350 1351 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1439 1441 1439 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1442 1444 1442 1444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1478 1486 1478 1486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1617 1619 1617 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1718 1719 1718 1719 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1791 1792 1791 1792 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1910 1911 1910 1911 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2168 2169 2168 2169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 17 22 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 65 70 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 217 221 <span type="species:ncbi:10090">Tg26</span>
###xml 255 260 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 368 373 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 374 389 <span type="species:ncbi:10090">transgenic mice</span>
###xml 408 413 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 617 622 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 858 863 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 955 960 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1137 1142 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1683 1688 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1740 1745 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1933 1938 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1991 1996 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Prior studies in HIV-1 transgenic animals support the model that HIV-1 gene products interact with endogenous mitogenic pathways in infected renal epithelium. [11-14]. Kidney transplants between normal and transgenic Tg26 siblings suggested that specific HIV-1 proteins within the kidney, and not circulating factors, transform infected renal epithelium [13]. Indeed, HIV-1 transgenic mice generated with an HIV-1 proviral construct mutated in the Nef "PXXP" SH3-binding motif for Src-family kinases failed to develop nephropathy [31], and a recent in vitro analysis of podocytes infected with single gene mutants of HIV-1 further suggest that Nef plays a central role in causing the proliferative phenotype in HIVAN [8]. Utilizing these same single gene mutant viruses, we showed here that Nef appears to be play a role in the up-regulation of cyclin D1 by HIV-1 in vitro. Importantly, these single gene mutants do not exclude the possibility that other HIV-1 gene(s) may cooperate with nef to induce cyclin D1, particularly tat, which is present in every virus. Cumulatively, however, these observations do suggest a mechanism whereby HIV-1 expression in renal epithelium may induce cyclin D1: activation of Src-family kinases by Nef would be expected to up-regulate cyclin D1 gene expression and promote the synthesis and stabilization of cyclin D1 protein via Src-Ras-MAPK and Src-PI3K-mTOR signal transduction pathways, respectively [32-34]. Interestingly, our unpublished in vitro observations and published data showing marked expression of basic fibroblast growth factor in the interstitium of HIVAN kidneys [35] suggest that soluble mitogens may be important cofactors with HIV-1 expression to induce cyclin D1. Thus, interrupting HIV-1 gene expression should down-regulate cyclin D1 and correct the phenotypic abnormalities in infected podocytes. In support of this notion, we show here that cyclin D1 expression parallels HIV-1 expression before, during, and after suppression of HIV-1 transcription with flavopiridol, and recently, we showed that longer periods of treatment with flavopiridol ameliorate the phenotypic abnormalities of infected podocytes [7].
###end p 25
###begin title 26
Conclusions
###end title 26
###begin p 27
###xml 83 84 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 95 96 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 146 147 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 255 256 253 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 398 399 396 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 459 463 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef.</italic>
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 427 432 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 453 458 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 494 497 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The following results of this study suggest that HIV-1 expression leads to cyclin D1-mediated G1 --> S progression in infected podocytes: cyclin D1 transcript and protein levels are markedly up-regulated, phospho-Rb (Ser780) levels are increased, cyclin D1 protein and phospho-Rb (Ser780) levels do not decrease with podocyte cell-cell contact and differentiation, and the up-regulation of cyclin D1 requires the expression of HIV-1 genes, particularly HIV-1 nef. In sum, these results suggest HIV-induced cell-cycle mechanisms may contribute to aberrant epithelial proliferation in HIVAN.
###end p 27
###begin title 28
Methods
###end title 28
###begin title 29
Podocyte cell culture and infection
###end title 29
###begin p 30
###xml 95 97 95 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ts</italic>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 382 383 382 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 834 836 828 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ts</italic>
###xml 943 945 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 946 948 934 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 178 183 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 253 258 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 343 348 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 604 608 <span type="species:ncbi:9913">calf</span>
Murine podocytes immortalized with interferon-inducible temperature-sensitive SV-40 T antigen (ts-SV-40 T) were isolated and infected with replication incompetent GFP-expressing HIV-1 virus, replication incompetent GFP-expressing single-gene mutants of HIV-1, or replication incompetent GFP-expressing control lentivirus containing GFP but no HIV-1 genes as previously described [7,8]. In all cases, 70% to 80% of podocytes showed GFP expression 4 days post infection (data not shown). Podocytes were used before passage twenty and maintained in RPMI 1640 (Life Technologies) supplemented with 10% fetal calf serum, 1 x PenStrep (Life Technologies), and 20 U/ml recombinant interferon-gamma (Life Technologies) at 33degreesC. Unless otherwise indicated, all studies were conducted at cell confluency and 14 days after inactivation of ts-SV-40 T at the non-permissive temperature (37degreesC) when wild-type podocytes are fully differentiated [27,28].
###end p 30
###begin title 31
Immunohistochemistry
###end title 31
###begin p 32
###xml 30 34 <span type="species:ncbi:10090">Tg26</span>
###xml 909 915 <span type="species:ncbi:9986">rabbit</span>
###xml 978 984 <span type="species:ncbi:9986">rabbit</span>
Kidneys from three 40 day-old Tg26 heterozygous transgenic siblings demonstrating 2+ proteinuria (Chemstrip 2GP, Roche) and three of their non-transgenics littermates were collected in accordance with Animal Use and Care Committee guidelines, fixed (10% buffered formalin), then paraffin-embedded (Department of Pathology, Mount Sinai School of Medicine). Four micron full coronal kidney sections from each animal were adhered to lysine-coated slides and used for immunodetection of phospho-Rb (Ser780) as follows: sections were deparaffinized and hydrated by placing in xylene for 8 minutes, followed by 3 minutes each of 100%, 96%, 80%, 70%, 50%, 30% ethanol, ending with 10 minutes in water; sections then underwent antigen retrieval (Glyca Reagent, Biogenex) followed by immunodetection (Super Sensitive Detection Kit, Biogenex) of phospho-Rb (Ser780) after a 12 hour incubation with a 1:1000 dilution of rabbit anti-phospho-Rb (Ser780) antibody (Cell Signaling) or control rabbit anti-sera (Biogenex) at 4degreesC.
###end p 32
###begin title 33
Immunofluorescence
###end title 33
###begin p 34
###xml 188 189 188 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 434 435 428 429 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 916 917 910 911 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 114 119 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 414 420 <span type="species:ncbi:9986">rabbit</span>
###xml 483 489 <span type="species:ncbi:9986">rabbit</span>
###xml 655 661 <span type="species:ncbi:9793">donkey</span>
###xml 667 673 <span type="species:ncbi:9986">rabbit</span>
Following the 14 day podocyte differentiation protocol on coverslips to establish mature podocytes, wild-type and HIV-1 infected podocytes underwent immunofluorescent detection of cyclin D1 as follows: coverslips were washed three times with 1 x PBS, fixed in 60% acetone/3.7% formaldehyde at -20degreesC for 20 minutes, then washed twice with 1 x PBS; the coverslips where then incubated with a 1:200 dilution of rabbit anti-cyclin D1 antibody (Santa Cruz Biotechnology) or control rabbit sera (Biogenex) for 2 hours at room temperature followed by three washes with 1 x PBS; the coverslips were then incubated with a 1:250 dilution of rhodamine-labeled donkey-anti-rabbit anti-sera (Chemicon) for 45 minutes to detect the primary antibody; following three final washes with 1 x PBS, the coverslips were mounted on glass slides using ProLong Antifade (Molecular Probes) for fluorescent detection of GFP and cyclin D1 on an Olympus IX70 microscope at 100 x magnification.
###end p 34
###begin title 35
Podocyte cell-cell contact
###end title 35
###begin p 36
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 75 80 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 911 916 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Total RNA and protein were extracted from wild-type, control-infected, and HIV-1 infected podocytes during the Reiser, et al. protocol to study subconfluent podocyte growth and podocyte growth during establishment of mature cell-cell contacts between differentiated podocytes [27,28]. Briefly, RNA and protein were extracted from parallel plates of podocytes using TRIZOL Reagent or RIPA buffer, respectively, under three conditions: 1) during sub-confluent growth at 33degreesC; 2) immediately upon reaching confluency (day zero); and 3) on day 14 after switching confluent cultures to 37degreesC. At the end of the differentiation protocol (day 14), additional plates were stained to detect foci formation as follows: cells were washed with 1 x PBS, fixed in methanol for 1 minute, stained with bromophenol blue for 1 minute, then washed again with 1 x PBS. In experiments utilizing the single gene mutant of HIV-1, total RNA was extract from infected podocytes 14 days after switching confluent cultures to 37degreesC. All experiments were performed twice.
###end p 36
###begin title 37
Flavopiridol treatment
###end title 37
###begin p 38
###xml 111 116 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 275 280 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
After the 14-day podocyte differentiation protocol described above, total RNA was extracted from wild-type and HIV-1-infected podocytes before treatment with flavopiridol (Developmental Therapeutics Program, National Cancer Institute) (day 14), two days after suppression of HIV-1 transcription with media containing 50 nM flavopiridol (day 16), and one day after drug washout using media without flavopiridol (day 17). The experiment was performed twice.
###end p 38
###begin title 39
###xml 8 9 8 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
Cyclin D1 transcript and protein
###end title 39
###begin p 40
###xml 125 132 124 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nef-LTR</italic>
###xml 133 134 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 151 152 150 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 250 251 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 357 358 355 356 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 418 419 416 417 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 119 124 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 137 142 <span type="species:ncbi:10090">mouse</span>
###xml 184 189 <span type="species:ncbi:10090">mouse</span>
###xml 398 404 <span type="species:ncbi:9986">rabbit</span>
###xml 504 509 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 658 664 <span type="species:ncbi:9986">rabbit</span>
###xml 762 768 <span type="species:ncbi:9986">rabbit</span>
RNA and protein samples were analyzed as follows: Podocyte RNA (10 mug) was analyzed by northern blot using probes for HIV-1 nef-LTR[7], mouse cyclin D1 (cDNA generated by RT-PCR from mouse podocytes and verified by sequence analysis), synaptopodin [7], and G3PDH. Following 7.5% SDS/PAGE, podocyte protein (20 mug) was analyzed by western blot for cyclin D1 (ECL detection of a 1:1000 dilution of rabbit anti-cyclin D1 antibody, Santa Cruz BioTechnology). Protein (250 mug) from the control-infected or HIV-1-infected podocytes on day 14 of the differentiation protocol was also analyzed by western blot for total pRb (ECL detection of a 1:1000 dilution of rabbit anti-Rb, Santa Cruz Biotechnology) and phospho-Rb (Ser780) (ECL detection of a 1:500 dilution of rabbit anti-phospho-Rb (Ser780) antibody binding, Cell Signaling). Protein concentrations were determined using the Bio-Rad Protein Assay (Bio-Rad Laboratories), and blotting of equivalent amounts of protein was confirmed by transient staining of membranes with Ponceau S solution (0.5% Ponceau S/1% acetic acid) and by western blot for beta-actin (Chemicon). Signal intensity was calculated using the UN-SCAN-IT gel v4.3 (Silk Scientific).
###end p 40
###begin title 41
Authors' contributions
###end title 41
###begin p 42
###xml 266 271 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
P.J.N. conceived and designed the study; performed the immunohistochemistry, immunofluorescence, and western blotting; and drafted the manuscript. M.S. cultured the podocytes and performed the northern blotting. M.H. designed and prepared the single gene mutants of HIV-1. I.H.G. mentored the authors and participated in the study's design and coordination.
###end p 42
###begin title 43
Acknowledgements
###end title 43
###begin p 44
###xml 58 63 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 80 84 <span type="species:ncbi:10090">Tg26</span>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
We thank Paul Klotman for the use of podocyte cell-lines, HIV-1 constructs, and Tg26 mice. This work was supported by a National Kidney Foundation Research Award (P.J.N) and by the NIH grant DK 56492-02.
###end p 44
###begin article-title 45
###xml 40 68 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 96 99 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 148 151 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments.
###end article-title 45
###begin article-title 46
###xml 53 56 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 80 83 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS.
###end article-title 46
###begin article-title 47
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Emerging concepts in gastrointestinal aspects of HIV-1 pathogenesis and management.
###end article-title 47
###begin article-title 48
###xml 65 70 <span type="species:ncbi:9606">human</span>
Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: role in podocyte proliferation and maturation.
###end article-title 48
###begin article-title 49
Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies.
###end article-title 49
###begin article-title 50
###xml 0 28 <span type="species:ncbi:12721">Human immunodeficiency virus</span>
Human immunodeficiency virus-1 induces loss of contact inhibition in podocytes.
###end article-title 50
###begin article-title 51
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytes.
###end article-title 51
###begin article-title 52
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Nef Induces Proliferation and Anchorage-Independent Growth in Podocytes.
###end article-title 52
###begin article-title 53
###xml 137 140 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy.
###end article-title 53
###begin article-title 54
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 74 77 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy.
###end article-title 54
###begin article-title 55
###xml 0 3 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 30 45 <span type="species:ncbi:10090">transgenic mice</span>
###xml 57 62 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-associated nephropathy in transgenic mice expressing HIV-1 genes.
###end article-title 55
###begin article-title 56
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 118 153 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes.
###end article-title 56
###begin article-title 57
###xml 15 43 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 46 61 <span type="species:ncbi:10090">transgenic mice</span>
Nephropathy in human immunodeficiency virus-1 transgenic mice is due to renal transgene expression.
###end article-title 57
###begin article-title 58
###xml 3 8 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 20 23 <span type="species:ncbi:10116">rat</span>
###xml 38 41 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction.
###end article-title 58
###begin article-title 59
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1: fifteen proteins and an RNA.
###end article-title 59
###begin article-title 60
DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1.
###end article-title 60
###begin article-title 61
The apoptotic v-cyclin-CDK6 complex phosphorylates and inactivates Bcl-2.
###end article-title 61
###begin article-title 62
Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
###end article-title 62
###begin article-title 63
v-Src's hold over actin and cell adhesions.
###end article-title 63
###begin article-title 64
Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.
###end article-title 64
###begin article-title 65
Cyclin D1 is a nuclear protein required for cell cycle progression in G1.
###end article-title 65
###begin article-title 66
Differential changes of cell cycle regulators and activities in kidneys during pre- and postnatal development.
###end article-title 66
###begin article-title 67
Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis.
###end article-title 67
###begin article-title 68
The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
###end article-title 68
###begin article-title 69
Emerging targets: Molecular mechanisms of cell contact-mediated growth control.
###end article-title 69
###begin article-title 70
###xml 48 52 <span type="species:ncbi:10116">rats</span>
Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis.
###end article-title 70
###begin article-title 71
The glomerular slit diaphragm is a modified adherens junction.
###end article-title 71
###begin article-title 72
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.
###end article-title 72
###begin article-title 73
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Flavopiridol inhibits P-TEFb and blocks HIV-1 replication.
###end article-title 73
###begin article-title 74
Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo.
###end article-title 74
###begin article-title 75
###xml 21 49 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 79 94 <span type="species:ncbi:10090">transgenic mice</span>
The pathogenicity of human immunodeficiency virus (hiv) type 1 nef in cd4c/hiv transgenic mice is abolished by mutation of its sh3-binding domain, and disease development is delayed in the absence of hck.
###end article-title 75
###begin article-title 76
Transformation by v-Src: Ras-MAPK and PI3K-mTOR mediate parallel pathways.
###end article-title 76
###begin article-title 77
Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway.
###end article-title 77
###begin article-title 78
Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability.
###end article-title 78
###begin article-title 79
###xml 59 62 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 89 104 <span type="species:ncbi:10090">transgenic mice</span>
bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice.
###end article-title 79

